In light of the global COVID-19 outbreak, the U.S. Food and Drug Administration (FDA) outlined new proposals in a statement that would enable the agency to prevent or mitigate medical product shortages. These proposals include requiring risk management plans, improved data sharing and requiring more accurate supply chain information, and reporting requirements for device manufacturers. Companies can stay in compliance and better mitigate future supply chain risks by adopting Internet of Things (IoT) technology solutions, such as real-time monitoring and visibility services for in-transit goods and remote assets.
The KORE Critical Asset Management solution is an advanced, comprehensive solution to visualize and mitigate the risks associated with global, multi-modal supply chain operations. The solution provides enhanced visibility into the location and condition of goods with real-time GPS location information, as well as data on temperature, shock, and tilt events occurring anywhere around the globe. This not only improves tracking, but it also helps ensure compliance with policies required for chain-of-custody and temperature-controlled supply chains.
During this webinar, we will discuss the recent FDA proposals and how pharmaceutical companies and medical device manufacturers can stay ahead of the proposed requirements by adopting IoT technology for advanced supply chain visibility.